| Literature DB >> 22783429 |
Chibo Liu1, Chunqin Pan, Jianmin Shen, Haibao Wang, Liang Yong.
Abstract
The purpose of this study was to screen serum samples from gastric carcinoma patients and to determine whether serum amyloid A protein (SAA) served as a biomarker. SELDI technology was used to screen for changes in SAA levels in the serum samples. A mass cluster with a mass/charge (m/z) value between 11.1 and 11.9 kDa was identified in the serum samples from gastric carcinoma patients which was much higher than that of the control group. Furthermore, the increase in this m/z peak correlated with the severity of the cancer. High-performance liquid chromatography (HPLC) analysis confirmed that the peak was SAA1. In conclusion, this increase in SAA may be used as a potential biomarker for gastric cancer.Entities:
Year: 2012 PMID: 22783429 PMCID: PMC3392590 DOI: 10.3892/ol.2012.664
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967